FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29209011000001109: Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    91402701000001117 Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    91402801000001114 Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Desogestrel 150microgram / Ethinylestradiol 20microgram tablets 63 tablet false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has AMP Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Desogestrel false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start